M42 Provides Update on Fairfax-Epirus Teaming Agreement and Future OpportunityAgreement expected to generate $250MM initial annual EBITDA and free cash flow as M42 explores strategic transaction with AIAI Holdings
M42 signals genomics expansion with strategic partnership with Uzbekistan’s Ministry of Health on the Uzbek Genome ProgramABU DHABI, United Arab Emirates, Jan. 29, 2025 (GLOBE NEWSWIRE) -- In a sign of its ambition to expand its foothold in genomics and grow its contribution to global genomics diversity, M42 and Uzbekistan’s Ministry of Health have signed a Memorandum of Understanding (“MoU”) to collaborate and explore opportunities for strategic partnerships on the Uzbek Genome Program.
M42’s Danat Al Emarat Hospital for Women & Children partners with ProFaM to offer revolutionary reproductive health servicesABU DHABI, United Arab Emirates, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Danat Al Emarat Hospital for Women & Children, part of the M42 group, has announced an exclusive partnership with UK-based ProFaM to perform ovarian tissue cryopreservation (OTC), offering an innovative solution for women looking to preserve their fertility or delay menopause naturally. The announcement was made at Arab Health 2025, marking a key moment in the UAE’s continued efforts in advancing women's health and fertility solutions.
M42 Announces New Clinical LLM to Transform the Future of AI in Healthcare
M42, a global tech-enabled healthcare network, has unveiled an impactful advancement in healthcare technology with the launch of Med42, a new open-access Clinical Large Language Model (LLM). The 70 billion parameter, generative artificial intelligence (AI) model is poised to transform the future of AI across the healthcare sector and create a direct impact on patient care outcomes.
